Nabeshima T, Hiramatsu M, Furukawa H, Kameyama T
Life Sci. 1985 Mar 11;36(10):939-46. doi: 10.1016/0024-3205(85)90389-3.
The effects of phencyclidine (PCP) on the levels of serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) in discrete brain areas of mouse were investigated. Following a single administration, PCP significantly increased at 60 min the level of 5-HT but not 5-HIAA in the cortex. However, acute administration of PCP induced no changes of 5-HT and 5-HIAA levels in other brain areas investigated. On the other hand, chronic treatment of PCP produced a significant increase the striatal 5-HT and 5-HIAA levels by about 30% and 20%, respectively. These increased levels were gradually returned to the control levels, and there was no difference of these levels between the control group and the 48 hr withdrawal group. The changes of 5-HT level in the hypothalamus were similar to those in the striatum. These results suggest that the pharmacological actions of PCP and tolerance development to PCP may be related to the functional changes of serotonergic neuronal activity.
研究了苯环己哌啶(PCP)对小鼠离散脑区血清素(5 - HT)和5 - 羟吲哚乙酸(5 - HIAA)水平的影响。单次给药后,PCP在60分钟时显著增加了皮质中5 - HT的水平,但未增加5 - HIAA的水平。然而,急性给予PCP并未引起所研究的其他脑区5 - HT和5 - HIAA水平的变化。另一方面,PCP的慢性治疗使纹状体中5 - HT和5 - HIAA水平分别显著增加了约30%和20%。这些增加的水平逐渐恢复到对照水平,并且对照组和48小时戒断组之间这些水平没有差异。下丘脑中5 - HT水平的变化与纹状体中的相似。这些结果表明,PCP的药理作用以及对PCP的耐受性发展可能与血清素能神经元活动的功能变化有关。